Biocompatibles Lens Unit Divestiture Could Ripen Firm For Abbott Purchase
Biocompatibles' divestiture of its Eye Care division to Cooper Companies converts the British firm into a pure-play entity in the coronary and drug-coated stent market
Biocompatibles' divestiture of its Eye Care division to Cooper Companies converts the British firm into a pure-play entity in the coronary and drug-coated stent market